Venlafaxine 37.5mg Tablets

Manufacturer ZYDUS PHARMACEUTICALS (USA) Active Ingredient Venlafaxine Tablets(ven la FAX een) Pronunciation VEN-la-FAX-een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidepressant
🧬
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🀰
Pregnancy Category
C
βœ…
FDA Approved
Dec 1993
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Venlafaxine is a medication used to treat depression, anxiety, and panic disorder. It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain, which can improve mood and reduce anxiety.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow these guidelines:

Take your medication exactly as directed by your doctor.
Read and follow all instructions provided with your medication.
Take your medication with food to help your body absorb it properly.
Establish a routine by taking your medication at the same time every day.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

Storing and Disposing of Your Medication

To ensure your medication remains effective and safe:

Store your medication at room temperature in a dry location, away from bathrooms.
Keep all medications in a secure place, out of reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider.
Check with your pharmacist for guidance on disposing of medications, and consider participating in local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Take the missed dose as soon as you remember.
If it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Take exactly as prescribed, usually with food to reduce stomach upset.
  • Do not stop taking this medication suddenly, as it can cause withdrawal symptoms. Your doctor will guide you on how to slowly reduce the dose if needed.
  • Avoid alcohol while taking venlafaxine, as it can increase side effects like dizziness and drowsiness.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it can cause dizziness or drowsiness.
  • Monitor your blood pressure regularly as advised by your doctor.
  • Report any unusual changes in mood or behavior, especially suicidal thoughts, to your doctor immediately.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 37.5 mg once daily for 4-7 days, then 75 mg once daily (immediate-release) or 75 mg once daily (extended-release)
Dose Range: 37.5 - 375 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Immediate-release: Initial 37.5-75 mg/day in 2-3 divided doses, titrate up to 375 mg/day. Extended-release: Initial 37.5-75 mg once daily, titrate up to 225 mg/day.
Generalized Anxiety Disorder (GAD): Extended-release: Initial 37.5-75 mg once daily, titrate up to 225 mg/day.
Social Anxiety Disorder (SAD): Extended-release: 75 mg once daily.
Panic Disorder (PD): Extended-release: Initial 37.5 mg once daily for 7 days, then 75 mg once daily.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for routine use; limited data for MDD in adolescents (e.g., 37.5 mg/day, titrate up to 225 mg/day for extended-release, with caution).
Adolescent: Limited data for MDD (e.g., 37.5 mg/day, titrate up to 225 mg/day for extended-release, with caution and close monitoring for suicidality).
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl 30-90 mL/min: No dosage adjustment needed.
Moderate: CrCl 10-29 mL/min: Reduce total daily dose by 50%.
Severe: CrCl <10 mL/min: Reduce total daily dose by 75%.
Dialysis: Reduce total daily dose by 50% and withhold dose until end of dialysis session (for immediate-release). For extended-release, reduce by 50% and administer after dialysis.

Hepatic Impairment:

Mild: Child-Pugh A: No dosage adjustment needed.
Moderate: Child-Pugh B: Reduce total daily dose by 50%.
Severe: Child-Pugh C: Reduce total daily dose by 50% or more, use with caution.

Pharmacology

πŸ”¬

Mechanism of Action

Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and weak inhibitors of dopamine reuptake. This leads to increased concentrations of these neurotransmitters in the synaptic cleft, enhancing their activity in the central nervous system.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 45% (due to first-pass metabolism)
Tmax: Venlafaxine: 2-4 hours (immediate-release), 5.5 hours (extended-release); ODV: 4-6 hours (immediate-release), 9 hours (extended-release)
FoodEffect: Food has no significant effect on the absorption or bioavailability of venlafaxine or ODV.

Distribution:

Vd: Approximately 7.5 L/kg
ProteinBinding: Venlafaxine: Approximately 27%; ODV: Approximately 30%
CnssPenetration: Yes

Elimination:

HalfLife: Venlafaxine: 5 Β± 2 hours; ODV: 11 Β± 2 hours
Clearance: Venlafaxine: 1.3 Β± 0.6 L/h/kg; ODV: 0.4 Β± 0.2 L/h/kg
ExcretionRoute: Renal (approximately 87% of a dose is excreted in urine within 48 hours, primarily as ODV and its conjugates)
Unchanged: Approximately 5% (venlafaxine); Approximately 29% (ODV)
⏱️

Pharmacodynamics

OnsetOfAction: Initial antidepressant effects may be seen within 1-2 weeks; full therapeutic effects may take 4-6 weeks.
PeakEffect: Not directly quantifiable for clinical effect, but steady-state plasma concentrations are typically achieved within 3 days for venlafaxine and 4-5 days for ODV.
DurationOfAction: Maintained with once-daily dosing for extended-release formulations due to long half-life of ODV.

Safety & Warnings

⚠️

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Venlafaxine is not approved for use in pediatric patients.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Difficulty focusing or memory problems
+ Feeling confused or weak
+ Seizures or changes in balance
Signs of bleeding, such as:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine or black, red, or tarry stools
+ Bleeding from the gums or abnormal vaginal bleeding
+ Unexplained bruises or bleeding that won't stop
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Passing out or changes in eyesight
Seizures
Chest pain or pressure
Shortness of breath
Cough
Bone pain
Sex problems, such as:
+ Decreased interest in sex
+ Difficulty having an orgasm or ejaculation problems
+ Trouble getting or maintaining an erection
A potentially life-threatening condition called serotonin syndrome, which may be more likely if you're taking certain other medications. Symptoms include:
+ Agitation or changes in balance
+ Confusion or hallucinations
+ Fever or fast/abnormal heartbeat
+ Flushing or muscle twitching/stiffness
+ Seizures or shivering/shaking
+ Excessive sweating or severe diarrhea, stomach upset, or vomiting
+ Severe headache

Other Possible Side Effects

Most medications can cause side effects, but many people experience none or only mild symptoms. If you're concerned about any of the following side effects or if they persist, contact your doctor:

Trouble sleeping
Feeling nervous, anxious, or excitable
Weight loss
Dizziness, drowsiness, tiredness, or weakness
Shakiness
Headache
Excessive sweating
Constipation, diarrhea, stomach upset, vomiting, or decreased appetite
Gas
Dry mouth
Strange or vivid dreams
* Yawning

This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • New or worsening thoughts of self-harm or suicide
  • Extreme agitation, restlessness, or irritability
  • Panic attacks
  • Difficulty sleeping (insomnia)
  • Unusual changes in behavior (e.g., aggression, impulsivity, mania)
  • Symptoms of serotonin syndrome (e.g., fever, sweating, confusion, muscle stiffness or twitching, severe diarrhea, shivering, agitation, hallucinations)
  • Severe headache, blurred vision, or pounding in your neck or ears (signs of high blood pressure)
  • Unusual bleeding or bruising
  • Seizures
  • Allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
πŸ“‹

Before Using This Medicine

Before taking this medication, it is essential to inform your doctor about the following:

Any allergies you have, including allergies to this drug, its components, or other substances, such as foods or medications. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have high blood pressure, as this may be a relevant factor in your treatment.
If you have narrow-angle glaucoma, a condition that affects the eyes.
If you are currently taking a weight loss medication, as this may interact with this drug.
If you are taking or have recently taken certain medications, including:
+ Linezolid or methylene blue, as these may interact with this drug.
+ Certain drugs for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days. Taking this drug with these medications may increase the risk of very high blood pressure.
It is crucial to note that this is not an exhaustive list of all potential interactions. Therefore, it is vital to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have. This will enable your healthcare team to assess the safety of taking this drug in conjunction with your other medications and health conditions.
* Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor to ensure your safety.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent any potential interactions with other treatments.

Until you know how this medication affects you, avoid driving and other activities that require you to be alert. This is crucial to prevent accidents and ensure your safety.

Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of side effects. In some cases, these side effects can be severe and long-lasting. If you need to discontinue this medication, your doctor will provide guidance on how to gradually stop taking it. Be sure to discuss any new or worsening symptoms with your doctor.

Regular blood pressure checks are necessary while taking this medication, as it may cause high blood pressure. Your doctor will advise you on the frequency of these checks.

It is recommended to avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, cannabis, or any prescription or over-the-counter medications that may cause drowsiness.

This medication may increase the risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor, especially if you have any concerns.

If you have bipolar disorder, be aware that this medication may trigger manic episodes. Contact your doctor immediately if you experience any symptoms of a manic episode.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess this risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, seek medical attention promptly.

Low blood sodium levels (hyponatremia) can occur with this medication, and in severe cases, it can be fatal. Discuss this risk with your doctor and report any concerns.

High cholesterol has been associated with this medication. If you have questions or concerns, consult your doctor.

This medication may affect certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication to ensure accurate test results.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

In some cases, this medication may affect growth in children and adolescents. Regular growth checks may be necessary, and your doctor will discuss this with you.

If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor. Taking this medication in mid to late pregnancy may increase the risk of health problems for both the mother (such as postpartum bleeding) and the newborn. Your doctor will help you weigh the benefits and risks of taking this medication during pregnancy or breastfeeding.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Mild tremor
  • Nausea
  • Vomiting
  • Dizziness
  • Tachycardia
  • Mydriasis
  • Seizures
  • QTc prolongation
  • Ventricular tachycardia
  • Bradycardia
  • Hypotension
  • Rhabdomyolysis
  • Vertigo
  • Coma
  • Death

What to Do:

Seek immediate medical attention or call 911. For poison control, call 1-800-222-1222. Treatment is generally supportive and symptomatic. Activated charcoal may be considered if ingested recently. Monitor cardiac rhythm and vital signs.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of serotonin syndrome (allow at least 14 days between discontinuing MAOI and starting venlafaxine, and at least 7 days between discontinuing venlafaxine and starting MAOI)
πŸ”΄

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) - increased risk of serotonin syndrome
  • Drugs that prolong the QT interval (e.g., Class IA and III antiarrhythmics, antipsychotics, macrolide antibiotics) - theoretical risk of QTc prolongation
  • Anticoagulants/Antiplatelets (e.g., warfarin, aspirin, NSAIDs) - increased risk of bleeding
  • CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine) - increased venlafaxine levels and decreased ODV levels, potentially altering efficacy/side effects
  • Alcohol - increased CNS depression and impaired psychomotor skills
🟑

Moderate Interactions

  • Cimetidine - inhibits first-pass metabolism of venlafaxine, increasing venlafaxine AUC (less significant for ODV)
  • Haloperidol - increased haloperidol AUC and Cmax
  • Imipramine - increased desipramine AUC
  • Metoprolol - increased metoprolol AUC and Cmax
  • Indinavir - decreased indinavir AUC and Cmax
  • Drugs affecting blood pressure (e.g., antihypertensives) - venlafaxine can cause dose-related increases in blood pressure
🟒

Minor Interactions

  • Not specifically listed as minor, but general caution with CNS depressants.

Monitoring

πŸ”¬

Baseline Monitoring

Psychiatric evaluation (mood, anxiety, suicidal ideation)

Rationale: To establish baseline symptom severity and identify risk factors for suicidality.

Timing: Prior to initiation

Blood pressure and heart rate

Rationale: Venlafaxine can cause dose-related increases in blood pressure and heart rate.

Timing: Prior to initiation

Weight

Rationale: To monitor for significant weight changes.

Timing: Prior to initiation

Renal and hepatic function tests

Rationale: To guide initial dosing adjustments in patients with impairment.

Timing: Prior to initiation (if impairment suspected)

πŸ“Š

Routine Monitoring

Psychiatric symptom assessment (efficacy, adverse effects, suicidal ideation)

Frequency: Weekly for first 4 weeks, then every 2-4 weeks, then periodically as clinically indicated.

Target: Symptom improvement, absence of worsening depression or suicidality.

Action Threshold: Worsening symptoms, emergence of suicidality, or intolerable side effects warrant dose adjustment or discontinuation.

Blood pressure and heart rate

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Within normal limits or patient's baseline.

Action Threshold: Sustained hypertension (e.g., >140/90 mmHg) or significant tachycardia warrants intervention (dose reduction, discontinuation, or antihypertensive therapy).

Weight

Frequency: Periodically (e.g., every 3-6 months).

Target: Stable weight.

Action Threshold: Significant weight gain or loss.

Electrolytes (especially sodium)

Frequency: Periodically, especially in elderly or those on diuretics.

Target: Normal sodium levels.

Action Threshold: Hyponatremia.

πŸ‘οΈ

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, aggression, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Serotonin syndrome symptoms (e.g., agitation, hallucinations, delirium, tachycardia, labile blood pressure, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, diarrhea)
  • Hypertension
  • Tachycardia
  • Nausea, vomiting, diarrhea, constipation
  • Dizziness, somnolence, insomnia
  • Sweating
  • Sexual dysfunction
  • Withdrawal symptoms upon discontinuation (e.g., dizziness, headache, nausea, insomnia, irritability, anxiety, paresthesia, fatigue, flu-like symptoms)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Exposure during the third trimester may lead to complications in the neonate.

Trimester-Specific Risks:

First Trimester: Limited data, but generally not associated with major congenital malformations.
Second Trimester: No clear evidence of increased risk of major malformations.
Third Trimester: Risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, constant crying) if exposed late in the third trimester.
🀱

Lactation

Venlafaxine and its active metabolite (ODV) are excreted into breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for venlafaxine, and any potential adverse effects on the breastfed infant.

Infant Risk: L3 (Moderate risk). Monitor infants for sedation, poor feeding, and poor weight gain. Some reports of adverse effects in breastfed infants (e.g., irritability, crying, sleep disturbances), but many infants show no adverse effects. Therapeutic drug monitoring of infant plasma levels may be considered.
πŸ‘Ά

Pediatric Use

Not approved for use in pediatric patients. Black Box Warning regarding increased risk of suicidal thoughts and behavior in children, adolescents, and young adults. Use in this population should be with extreme caution and close monitoring.

πŸ‘΄

Geriatric Use

Increased sensitivity to venlafaxine may occur in some elderly patients. Dosage adjustments may be necessary, especially in those with renal or hepatic impairment. Elderly patients may be at higher risk for hyponatremia and falls. Start with lower doses and titrate slowly.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Venlafaxine is an SNRI, affecting both serotonin and norepinephrine. At lower doses (<150 mg/day), it primarily acts as an SSRI; at higher doses, norepinephrine reuptake inhibition becomes more prominent.
  • Extended-release (XR) formulations are generally preferred due to once-daily dosing and potentially better tolerability (less nausea) compared to immediate-release (IR).
  • Blood pressure monitoring is crucial, especially during dose escalation, as venlafaxine can cause dose-dependent increases in blood pressure.
  • Discontinuation syndrome (withdrawal) is common and can be severe if discontinued abruptly. Tapering the dose slowly over several weeks is essential.
  • Patients should be advised to take venlafaxine with food to minimize gastrointestinal upset.
  • Caution is advised in patients with a history of seizures, narrow-angle glaucoma, or cardiovascular disease.
πŸ”„

Alternative Therapies

  • SSRIs (e.g., fluoxetine, sertraline, escitalopram, citalopram, paroxetine)
  • Other SNRIs (e.g., duloxetine, desvenlafaxine, levomilnacipran)
  • Atypical antidepressants (e.g., bupropion, mirtazapine, trazodone)
  • Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, nortriptyline)
  • MAOIs (e.g., phenelzine, tranylcypromine) - generally reserved for refractory cases due to significant interaction risks
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
πŸ’°

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (37.5mg immediate-release generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. Please read this guide carefully and review it again whenever you refill your prescription. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.